Reg. no. 5593100927 · Research and experimental development on biotechnology · STOCKHOLM
Oxion Biologics AB is registered with the legal form Limited company, is based in STOCKHOLM and is active in Research and experimental development on biotechnology. Revenue for 2024 was 2.9 MSEK.
Fiscal year ending 2024-12-31 · Amounts in SEK
Net revenue
2.9 MSEK
▲ >+1000%Operating result
-20.4 MSEK
▲ +44%Net result
-7.3 MSEK
▲ +80%Employees (annual report)
3
Total assets
46.7 MSEK
Equity
35.7 MSEK
Equity ratio
77 %
Profit margin
−255.1 %
One or more values below fall outside the ranges we normally see. These figures usually come straight from the company's filed annual report — check the original document (available above) before relying on them.
MSEK
Oxion Biologics AB increased net sales by 1,000 % to 2.9 MSEK in 2024. The operating margin for 2024 was -716.2 %, compared with -35,454 % a period earlier. Oxion Biologics AB generated roughly 951 kSEK in net sales per employee in 2024.
Calculated by ArkivNord from filed annual reports. Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge. About the methodology
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
Per the signatures in the annual report for the fiscal year ending 2024-12-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.
Oxion Biologics AB's reg. no. is 5593100927.
Oxion Biologics AB reported revenue of 2.9 MSEK for the fiscal year 2024.
No — Oxion Biologics AB reported a net result of -7.3 MSEK for 2024.
Oxion Biologics AB had 3 employees as of the most recently reported period (2024).
Oxion Biologics AB is registered under Research and experimental development on biotechnology.
Oxion Biologics AB is based in STOCKHOLM.
arkivnord